CT Financial Advisors’s Genomic Health, Inc. GHDX Stock Holding History

CT Financial Advisors’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$195K	Sell	6,182 -327	-5%	-$9.67K	0.12%	155
2016 Q4	$191K	Hold	6,509	–	–	0.12%	151
2016 Q3	$188K	Sell	6,509 -575	-8%	-$16K	0.12%	153
2016 Q2	$183K	Sell	7,084 -1,600	-18%	-$42.5K	0.11%	152
2016 Q1	$215K	Hold	8,684	–	–	0.12%	147
2015 Q4	$306K	Buy	8,684 +8,334	+2,381%	+$223K	0.18%	110
2015 Q3	$7.41K	Hold	350	–	–	﹤0.01%	488
2015 Q2	$9.73K	Hold	350	–	–	0.01%	476
2015 Q1	$10.7K	Buy	+350	New	+$11.1K	0.01%	456
2014 Q1	$10.7K	Buy	+350	New	+$10K	0.01%	456

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

CT Financial Advisors's GHDX Position: Q1 2017 in Review

CT Financial Advisors reduced its Genomic Health, Inc. (GHDX) stake by 5% in Q1 2017, selling an estimated $9.67K and leaving 6,182 shares worth $195K. The position accounts for 0.12% of the portfolio, ranked #155.

CT Financial Advisors first reported a position in GHDX in Q1 2014 and has held it in 10 quarters since. The position peaked at $306K in Q4 2015. 124 funds tracked by Wall St. Rank hold GHDX as of Q1 2017.

CT Financial Advisors held 6,182 shares of Genomic Health, Inc. worth $195K as of Q1 2017.
CT Financial Advisors sold 327 Genomic Health, Inc. shares in Q1 2017, an estimated $9.67K.
Genomic Health, Inc. made up 0.12% of CT Financial Advisors's portfolio in Q1 2017, its #155 holding.
CT Financial Advisors first reported a position in Genomic Health, Inc. in Q1 2014 and has held it in 10 quarters since.
CT Financial Advisors's Genomic Health, Inc. position peaked at $306K in Q4 2015.
124 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q1 2017.

Based on CT Financial Advisors's 13F filing for Q1 2017, filed 7 Apr 2017.